PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up

Key Takeaways PacBio reported Q4 revenues of $44.6M, up 13.8%, beating estimates.PACB's adjusted gross margin expanded 900 bps to 41%, operating loss narrowed.PACB guides 2026 revenue to $165-$180M, up 3-12% year over year.Pacific Biosciences of California, Inc. (PACB) , popularly known as PacBio, delivered an adjusted loss per share of 12 cents in fourth-quarter 2025, narrower than the year-ago adjusted loss of 20 cents per share. The adjusted loss per share topped the Zacks Consensus Estimate by 36.8%.The ...